Skip to main content
AVTX logo

AVTX

Avalo Therapeutics, Inc.
$18.42 -0.49 (-2.59%) At close · Jul 14
Market Cap
$968.26M
Shares
52,565,572

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 101
Total Value: $536,262,750
Total Shares: 35,918,473
Showing 1–100 of 110 holdings by value · page 1 of 2

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 101 13F filers · Δ vs Dec 31, 2025
Top Holder
8.4%
Dec 2023 → Mar 2026 · range 6.6% – 69.9%
+1.8 pts
Top 5
28.4%
Dec 2023 → Mar 2026 · range 28.0% – 99.7%
+0.3 pts
Top 10
46.2%
Dec 2023 → Mar 2026 · range 44.6% – 100.0%
+1.6 pts
HHI
318
Dec 2023 → Mar 2026 · range 300 – 5,245
Broadly held+18

Quarterly Activity

vs Dec 31, 2025
New
34
Increased
33
Decreased
20
Sold Out
18
Unchanged
14
Holder count: +16
Institutional value: +41.2%
Shares held: +71.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 110
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1534120 CUSIP 05338F306 13F (30d) 2 filings 2 filers Visit website Investor relations